159 related articles for article (PubMed ID: 1495991)
1. Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins.
Kunitake ST; Jarvis MR; Hamilton RL; Kane JP
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6993-7. PubMed ID: 1495991
[TBL] [Abstract][Full Text] [Related]
2. Isolation of subpopulations of high density lipoproteins: three particle species containing apoE and two species devoid of apoE that have affinity for heparin.
Hennessy LK; Kunitake ST; Jarvis M; Hamilton RL; Endeman G; Protter A; Kane JP
J Lipid Res; 1997 Sep; 38(9):1859-68. PubMed ID: 9323595
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of human lipoproteins isolated by selected-affinity immunosorption of apolipoprotein A-I.
McVicar JP; Kunitake ST; Hamilton RL; Kane JP
Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1356-60. PubMed ID: 6424116
[TBL] [Abstract][Full Text] [Related]
4. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
5. Prevention of in vitro low-density lipoprotein oxidation by an albumin-containing Lp A-I subfraction.
Decossin C; Tailleux A; Fruchart JC; Fiévet C
Biochim Biophys Acta; 1995 Mar; 1255(1):31-8. PubMed ID: 7893735
[TBL] [Abstract][Full Text] [Related]
6. Cholesterylester hydroperoxide reducing activity associated with isolated high- and low-density lipoproteins.
Sattler W; Christison J; Stocker R
Free Radic Biol Med; 1995 Mar; 18(3):421-9. PubMed ID: 9101232
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of metal-catalyzed oxidation of low-density lipoprotein by free and albumin-bound bilirubin.
Hulea SA; Wasowicz E; Kummerow FA
Biochim Biophys Acta; 1995 Oct; 1259(1):29-38. PubMed ID: 7492612
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of ultracentrifugation on apolipoprotein A-I-containing lipoprotein subpopulations.
Cheung MC; Wolf AC
J Lipid Res; 1988 Jan; 29(1):15-25. PubMed ID: 3128619
[TBL] [Abstract][Full Text] [Related]
9. Plasma lipid composition and LDL oxidation.
Brizzi P; Tonolo G; Carusillo F; Malaguarnera M; Maioli M; Musumeci S
Clin Chem Lab Med; 2003 Jan; 41(1):56-60. PubMed ID: 12636050
[TBL] [Abstract][Full Text] [Related]
10. The metabolic fate of apolipoprotein A-I-containing lipoproteins internalized into HepG2 cells: resecreted lipoproteins as a potent inducer for cholesterol efflux.
Sasahara T; Kobori S; Kasho M; Sato Y; Nishikawa T; Yano T; Takeda H; Shichiri M
Atherosclerosis; 1994 Apr; 106(2):179-90. PubMed ID: 8060378
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of lipoproteins containing apoprotein A-I on Cu2+-catalyzed oxidation of human low density lipoprotein.
Ohta T; Takata K; Horiuchi S; Morino Y; Matsuda I
FEBS Lett; 1989 Nov; 257(2):435-8. PubMed ID: 2511042
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of HepG2 cell-derived apolipoprotein A-I-containing lipoproteins on cholesteryl ester accumulation in macrophages.
Kawano T; Hakamata H; Ohta T; Ding Y; Yoshida M; Ueda S; Horiuchi S
Biochemistry; 1997 Aug; 36(32):9816-25. PubMed ID: 9245414
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of tryptophan oxidation in plasma lipoproteins by myeloperoxidase-generated HOCl.
Jerlich A; Hammel M; Nigon F; Chapman MJ; Schaur RJ
Eur J Biochem; 2000 Jul; 267(13):4137-43. PubMed ID: 10866816
[TBL] [Abstract][Full Text] [Related]
14. LDL and HDL oxidation and fatty acid composition in vegetarians.
Nagyová A; Krajcovicová-Kudlácková M; Klvanová J
Ann Nutr Metab; 2001; 45(4):148-51. PubMed ID: 11463997
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.
Castellani LW; Navab M; Van Lenten BJ; Hedrick CC; Hama SY; Goto AM; Fogelman AM; Lusis AJ
J Clin Invest; 1997 Jul; 100(2):464-74. PubMed ID: 9218525
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated LDL oxidation: the impact of transition metals and transferrin.
Van Campenhout A; Heytens E; Van Campenhout C; Lagrou AR; Manuel-y-Keenoy B
Biochem Biophys Res Commun; 2005 Dec; 338(3):1617-24. PubMed ID: 16288727
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of a human serum cholesteryl ester transfer protein.
Chajek T; Fielding CJ
Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3445-9. PubMed ID: 210460
[TBL] [Abstract][Full Text] [Related]
18. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
[TBL] [Abstract][Full Text] [Related]
19. Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at normal low-density lipoprotein cholesterol plasma levels.
Hansel B; Bonnefont-Rousselot D; Orsoni A; Bittar R; Giral P; Roussel R; Marre M; Mohammedi K; Bruckert E; Chapman MJ; Kontush A
J Clin Lipidol; 2016; 10(5):1172-81. PubMed ID: 27678434
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein C-I reduces cholesteryl esters selective uptake from LDL and HDL by binding to HepG2 cells and lipoproteins.
Krasteva V; Brodeur MR; Tremblay FL; Falstrault L; Brissette L
Biochim Biophys Acta; 2010 Jan; 1801(1):42-8. PubMed ID: 19761869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
